CAR-T Therapy(BK2113)
Increase:3
Decrease:7
Total:10
Total 10 records
| code | marketCap | change | rps50 | rps120 | rps250 | industry | sectors |
|---|---|---|---|---|---|---|---|
| 64.31M | +26.90% | 4 | 4 | 6 | Biotechnology | CAR-T Therapy | |
Amgen AMGN | 164.88B | -1.49% | 91 | 58 | 69 | Drug Manufacturers - General | ARK Portfolio;CAR-T Therapy;Weight Loss Drugs |
bluebird bio BLUE | 51.40M | +7.58% | 15 | 10 | 8 | Biotechnology | Top Gainers Yesterday;Gene Editing;CAR-T Therapy |
Gilead Sciences GILD | 138.73B | -0.69% | 95 | 92 | 93 | Drug Manufacturers - General | CAR-T Therapy;Cancer Research;Infectious Disease;Mpox (monkeypox) |
| 78.16B | -2.25% | 91 | 62 | 49 | Drug Manufacturers - General | CAR-T Therapy;Infectious Disease | |
Incyte INCY | 11.79B | +0.59% | 37 | 47 | 63 | Biotechnology | ARK Portfolio;CAR-T Therapy |
| 369.31B | -7.59% | 80 | 57 | 55 | Drug Manufacturers - General | CAR-T Therapy;Infectious Disease | |
Novartis AG NVS | 216.49B | -1.68% | 93 | 62 | 76 | Drug Manufacturers - General | CAR-T Therapy;Cancer Research |
Pfizer PFE | 139.18B | -3.16% | 56 | 44 | 50 | Drug Manufacturers - General | CAR-T Therapy;Cancer Research;Weight Loss Drugs;Infectious Disease |
Vericel VCEL | 2.16B | -3.44% | 27 | 62 | 40 | Biotechnology | CAR-T Therapy |